10 September 2026

Regulations for Handling Peptide Products in Healthcare Facilities

Reference: CIR-2026-00000167

Regulations for Handling Peptide Products in Healthcare Facilities

To: All licensed health facilities within the jurisdiction and the scope of competence of Dubai Health Authority. 

The Dubai Health Authority (DHA) highly values the continued support and constructive cooperation of its partners across the healthcare sector.

As part of DHA’s commitment to enhancing the quality and efficiency of healthcare services, strengthening compliance, transparency, and accountability, and promoting awareness of the legislation and regulations governing the healthcare sector in the Emirate of Dubai, the Health Regulation Sector – Health Control Department – Drug Control & Inspection Section is pleased to invite you to attend:

“Regulations for Handling Peptide Products in Healthcare Facilities”

The workshop will focus on Circular CIR-2026-00000107: Regulations for Handling Peptide Products in Healthcare Facilities, published on 29 July 2026 with the aim of enhancing awareness among healthcare facilities and healthcare professionals regarding the proper regulatory handling of Peptides in Dubai.

 

Important Note:
The workshop will be conducted in English. Healthcare facilities are therefore kindly requested to ensure the attendance of English-speaking representatives to enable full understanding and benefit from the workshop content.

 

Date: Friday, 11 September 2026
Time: 9:30 AM – 11:00 AM
Platform: Microsoft Teams
Attendance Link: 

Meeting-Join | Microsoft Teams

https://teams.microsoft.com/meet/376091180774101?p=2HhQiB8PYR2bV51OLy

 

We sincerely appreciate your continued support, cooperation, and commitment to regulatory compliance and to the ongoing enhancement of the quality and safety of healthcare services in the Emirate of Dubai.

 

Best Regards,

Health Control Department
Drug Control & Inspection Section
Health Regulation Sector – Dubai Health Authority